Overview

Pharmacokinetics Ertapenem Burns

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
0
Participant gender:
All
Summary
This study will examine the pharmacokinetics of ertapenem in ventilated badly (> 30% SCT) burn patients.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Nantes University Hospital
Treatments:
Ertapenem
Criteria
Inclusion Criteria:

- Patients aged 18 to 70 years

- Burned on 30 to 60% of their body surface

- Mechanical ventilation

- Hospitalized in the intensive care unit of Nantes University Hospital for less than 8
days.

- Which the family gave consent

- insured

Exclusion Criteria:

- Patients whose family refused to sign the consent for participation.

- Patients allergic to beta lactam

- Patients with renal failure with creatinine clearance <80 ml.mn-1

- Pregnant women

- Persons protected by the law